Sermorelin

FDA Approved

Sermorelin (GRF 1-29)

Category
Growth Hormone
Aliases
GRF 1-29, Geref
Administration
Subcutaneous injection

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Injection site redness

A common, typically mild, local skin reaction at the injection site.

Flushing

A temporary warm, reddened sensation in the skin, typically resolving on its own.

Headache

A commonly reported mild side effect.

Generally well-tolerated

Most users do not report significant adverse effects.